Estimation of allele frequency and association mapping using next-generation sequencing data by Kim, S. Y. et al.
RESEARCH ARTICLE Open Access
Estimation of allele frequency and association
mapping using next-generation sequencing data
Su Yeon Kim1*, Kirk E Lohmueller1, Anders Albrechtsen2, Yingrui Li3, Thorfinn Korneliussen4, Geng Tian3,5,6,
Niels Grarup7, Tao Jiang3, Gitte Andersen8, Daniel Witte9, Torben Jorgensen10,11, Torben Hansen7,12,
Oluf Pedersen7,8,13,14, Jun Wang3,4 and Rasmus Nielsen1,4
Abstract
Background: Estimation of allele frequency is of fundamental importance in population genetic analyses and in
association mapping. In most studies using next-generation sequencing, a cost effective approach is to use
medium or low-coverage data (e.g., < 15X). However, SNP calling and allele frequency estimation in such studies is
associated with substantial statistical uncertainty because of varying coverage and high error rates.
Results: We evaluate a new maximum likelihood method for estimating allele frequencies in low and medium
coverage next-generation sequencing data. The method is based on integrating over uncertainty in the data for each
individual rather than first calling genotypes. This method can be applied to directly test for associations in case/control
studies. We use simulations to compare the likelihood method to methods based on genotype calling, and show that
the likelihood method outperforms the genotype calling methods in terms of: (1) accuracy of allele frequency
estimation, (2) accuracy of the estimation of the distribution of allele frequencies across neutrally evolving sites, and (3)
statistical power in association mapping studies. Using real re-sequencing data from 200 individuals obtained from an
exon-capture experiment, we show that the patterns observed in the simulations are also found in real data.
Conclusions: Overall, our results suggest that association mapping and estimation of allele frequencies should not
be based on genotype calling in low to medium coverage data. Furthermore, if genotype calling methods are
used, it is usually better not to filter genotypes based on the call confidence score.
Background
The frequency of an allele in the population is a funda-
mental quantity in human statistical genetics. This quan-
tity forms the basis of many population and medical
genetic studies. Many evolutionary forces change allele
frequencies. Consequently, allele frequencies can be used
to infer past evolutionary events. For example, allele fre-
quencies at single nucleotide polymorphisms (SNPs) can
be used to infer the demographic history of a population
[1,2]. Patterns of allele frequency are also informative
about the possible effects of natural selection. After a
completed selective sweep, an excess of low-frequency
and high-frequency derived SNPs is expected around the
selected site [3-6]. Conversely, SNPs under the direct
influence of negative selection are expected to be at
lower frequency than predicted by demography alone
[7,8]. Many commonly used summary statistics in popu-
lation genetics like Tajima’s D [9], Fu and Li’s D [10], Fay
and Wu’s H [4] and FST [11] are direct functions of allele
frequencies. Allele frequencies also form the basis of
association studies between SNPs and common disease.
In their simplest form, case-control association studies
seek to quantify the difference in allele frequency
between cases (individuals with the disease) and controls
(individuals without the disease) [12-14]. In particular,
there has been rapidly growing interest in performing
association studies between rare variants and common
disease using data obtained from next-generation
sequencing approaches [15-17].
Given the importance of allele frequencies in genetic
studies, it is critically important to be able to estimate
them reliably. Traditionally, allele frequencies were simply
estimated by counting the number of times each allele had
been seen in a sample from the population. This approach
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was often successfully used on SNP genotype data and
Sanger sequencing data because the genotypes for each
individual could often be unambiguously determined.
However, this approach may fail when applied to data
from next-generation sequencing technology. First, next-
generation sequencing data has a higher error rate than
traditional Sanger sequencing or SNP genotyping assays
[18-20]. Second, in order to sequence more samples,
researchers often sequence each individual at shallow cov-
erage (e.g., [21]). Thus, each base will only be covered by a
few reads, making it more difficult to accurately infer an
individual’s genotype at a particular site [20]. Finally,
because the reads from next-generation sequencing tech-
nologies are often quite short, additional errors can occur
when trying to align the short reads back to the reference
genome [22,23]. For these reasons, estimating allele fre-
quencies remains challenging.
Several different approaches have been proposed to
attempt to make accurate inferences of allele frequency
from next-generation sequencing technologies [24-31]. It
is important to appreciate that no single approach has
been consistently favored or endorsed by the community.
Instead, a variety of approaches have been proposed and
used by different scientific groups. The first set of
approaches uses the traditional paradigm of estimating
allele frequencies by first inferring individual genotypes
[23,32-34] and then tabulating frequencies. Here, strict
filters are used to attempt to account for the increased
error rate and uncertainty inherent in the data [20,35].
Others have added linkage disequilibrium (LD) informa-
tion and data from reference haplotypes to make more
accurate genotype calls [21,36]. The second set of
approaches seeks to directly estimate allele frequencies
from the next-generation sequencing data without first
attempting to infer genotypes [29-31]. These approaches
have the advantage that they directly estimate the quan-
tity of interest without first inferring other uncertain
information (e.g., the individual genotypes). The utility of
this type of approach has yet to be fully explored for dif-
ferent types of population and medical genetic studies.
Here we discuss the properties of a new likelihood
approach designed to estimate the population minor allele
frequency from next-generation sequencing data. We
show that the new likelihood method can obtain accurate
estimates of allele frequencies, even when the depth of
coverage is quite shallow. Further, we show that the new
likelihood method either performs as well as, or better
than, genotype calling methods. Finally, we discuss the
performance of the likelihood approach in testing for dif-
ferences in allele frequency between cases and controls.
Results
The minor allele is the less frequent allele in the popula-
tion at a variable site. We first describe two main
approaches to estimate the minor allele frequency
(MAF) at a particular site in the genome. The first
approach involves inferring individual genotypes and
treating those inferred genotypes as being completely
accurate when estimating the MAF. We then examine
the performance of a likelihood framework that directly
takes the uncertainty in assigning genotypes into
account. Throughout our work, we assume that all seg-
regating sites are biallelic.
Estimation of MAF from called genotypes
One way to estimate the MAF from next-generation
sequencing data is to first call a genotype for each indi-
vidual using sequencing data, and then use those geno-
types as if they are the true ones. This was the approach
traditionally used for genotype data and Sanger sequen-
cing data. It is not clear how well it will perform when
applied to next-generation sequencing data.
A maximum likelihood approach can be used to infer
the genotype for each individual from the next-genera-
tion sequencing data. At each site j, for each individual
i, the likelihood for each of the three possible genotypes
(assuming that we know the minor allele) is given as:
Lgi,j = P(Di,j|gi,j,E ,Q), gi,j ∈ {0, 1, 2}, (1)
where Di,j is the observed sequencing data in indivi-
dual i at site j, gi,j Î {0, 1, 2} is the number of minor
alleles contained in the genotype of each individual, and
E and Q control for sequencing errors and read base
qualities, respectively. The observed sequencing data for
each individual can be thought of as the alignment of
reads at site j taking the read quality scores into
account. This is represented as the genotype likelihood
and is found in the genotype likelihood file (GLF) which
is produced in many programs that analyze next-genera-
tion sequencing data, such as SOAPsnp and MAQ
[23,32].
To assign a genotype to a particular individual, the
likelihood of each of the three possible genotypes can be
calculated for the individual. The genotype with the
highest likelihood can then be assigned. However,
researchers often prefer a more stringent calling criter-
ion and will not assign a genotype to an individual
unless the most likely genotype is substantially more
likely than the second most likely one. Here the three
possible genotypes are sorted by their likelihoods:
(Lg(1) , Lg(2) , Lg(3) ) , where g(k) corresponds to the genotype
with the kth largest likelihood. With a given threshold f,
one can call the genotype g(1) if log10
(
Lg(1)
Lg(2)
)
> f .
Otherwise, a genotype is not called and the individual’s
genotype is considered missing. A common threshold
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value of f is 1, indicating that the most likely genotype is
at least 10 times more likely than the second most likely
one. Note that this type of filtering may result in higher
confidence for the “called” genotype, but it also results
in more missing data.
Maximum likelihood estimator of allele frequency
Instead of estimating the MAF from the called geno-
types, a maximum likelihood (ML) method introduced
by Kim et al. [30] (see also Lynch [29] for a similar
approach) directly estimates MAFs and takes genotype
uncertainty into account. Specifically, given a minor
allele, the probability of observing the sequence data at
each individual i is obtained by summing over the prob-
abilities corresponding to all three possible genotypes.
Suppose that the three genotype likelihoods defined in
Equation 1 are available. Using the same notation as
above, let Dj and pj be the observed sequencing data at
site j and the corresponding MAF, respectively. The
genotype probability given that minor allele frequency
can be computed by assuming Hardy-Weinberg equili-
brium (HWE). Then, assuming independence among
individuals, the likelihood of the MAF at this locus is a
product of all the likelihoods computed across all N
individuals:
P(Dj|pj,E ,Q) =
N∏
i=1
P(Di,j|pj,E ,Q)
=
N∏
i=1
2∑
gi,j=0
P(gi,j|pj)P(Di,j|gi,j,E ,Q)
(2)
The ML estimate of pj can be computed either by
directly maximizing the likelihood for a restricted para-
meter space using the Broyden-Fletcher-Goldfarb-
Shanno (BFGS) method [37-40] or by using the expecta-
tion-maximization (EM) algorithm [31,41]. When using
the EM algorithm, the posterior expectation of a geno-
type is computed for each individual, and the mean of
those posteriors is repeatedly updated. Our implementa-
tion of BFGS was faster than the EM algorithm. For
example, to obtain estimates from 100,000 sites, BFGS
took ~16 seconds but EM took ~100 seconds. However,
the difference in speed may be implementation specific.
In our case, for both methods, we stopped updating
parameters when the increase in the likelihood was less
than 0.001.
Maximum likelihood estimator with uncertain minor allele
In practice, often the second most common nucleotide
across individuals can be used as the minor allele. How-
ever, for rare SNPs (e.g., MAF < 1%), it is hard to deter-
mine which allele is the minor allele, since all four
nucleotides may appear in some reads due to sequen-
cing errors. To deal with this situation, we now describe
a likelihood framework that takes the uncertainty in the
determination of the minor allele into account.
Suppose that for site j we know the major allele M.
Note that deciding which of two common alleles is
likely to be the major one is not important since we are
mostly concerned with estimating the frequencies at
rare SNPs. Further, for alleles with intermediate fre-
quencies (around 50%), the distinction between major
and minor allele is less important. Assign the other
three non-major nucleotides m1, m2, and m3. The likeli-
hood introduced in Equation 2 assumes a fixed major
allele M and fixed minor allele m. Therefore, to allow
for uncertainty in the designation of the minor allele,
the likelihood function can be modified as:
P(Dj|pj,M,E ,Q) =
3∑
h=1
P(minor = mh)P(Dj|pj,M,minor = mh,E ,Q) (3)
Further, assuming that any of the three possible minor
alleles is equally likely, we obtain:
P(Dj|pj,M,E ,Q) = 13(e
l1 + el2 + el3) (4)
where lh = log P(Dj|pj,M,minor = mh,E ,Q) . Since elh
can be very small with big data sets (e.g., with many
individuals), it is useful to compute the likelihood in the
log-scale. Order the three conditional log-likelihoods as
to (l(1), l(2), l(3)), where l(1) is the largest one. Then,
log P(Dj|pj,M,E ,Q) = − log 3 + l(1) + log(1 + el(2)−l(1) + el(3)−l(1) )
G-test using called genotypes for association mapping
In association studies, SNPs showing significant differ-
ences in allele frequency between cases and controls are
said to be associated with the phenotype of interest.
Association mapping can be performed using data from
next-generation sequencing studies. We first discuss
approaches that require calling individual genotypes and
then perform a test for association using the called gen-
otypes. In this approach, a genotype is first called for
each individual. The genotypes can be filtered or unfil-
tered. Assuming independence across individuals and
HWE, a 2 × 2 contingency table can be built by count-
ing the number of major and minor alleles in both the
cases and controls. This leads to the well-known likeli-
hood ratio test for independence, the G-test:
G = 2
∑
k,h
Ok,h log
(
Ok,h
Ek,h
)
, (5)
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where Ok,h is the frequency observed in a cell, and Ek,h
is the frequency expected under the null hypothesis in
which the allele frequency is the same between cases
and controls. The well-known Pearson’s chi-square test
is asymptotically equivalent to the G-test. If the table is
generated from true genotypes, then the G-statistic
asymptotically follows a chi-square distribution with 1
degree of freedom (c2(1)). However, in our studies, we
construct the G-statistic using “called” genotypes, thus
HWE may not hold due to over- and under-calling of
heterozygotes. Furthermore, constructing the test statis-
tic by counting “called” genotypes instead of “observed”
genotypes likely introduces extra variability. Therefore,
the statistical theory may not be valid any more. Note
that when a genotype is not called for a certain indivi-
dual, the data is considered missing and is not included
in the 2 × 2 table.
Likelihood ratio test accounting for uncertainty in the
observed genotypes for association mapping
Instead of calling genotypes, the likelihood framework
allows for uncertainty in the genotypes and tests at each
site j whether the allele frequency is the same between
cases and controls. Formally, we compute the likelihood
of the hypotheses HO : pj,1 = pj,2(= pj,0) and HA : pj,1 ≠
pj,2, where pj,1 and pj,2 are the MAFs in cases and con-
trols, respectively.
Assuming that minor (m) and major (M) alleles are
known, the likelihood of the minor allele frequency can
be computed as described in Equation 2, and the likeli-
hood ratio test statistic is computed as:
LRT = −2 log
⎛⎝ P(Dj|pˆj,0,M,m,E ,Q)
P(D(1)j |pˆj,1,M,m,E ,Q)P(D(2)j |pˆj,2,M,m,E ,Q)
⎞⎠ (6)
where D(1)j and D
(2)
j are the observed data for cases
and controls, respectively, and pˆj,1 and pˆj,2 are the
MLEs of the MAFs in cases and controls, respectively.
If the minor allele is unknown, the likelihood under
the null hypothesis is computed as in Equation 3, and
the LRT statistic is modified as:
LRT = −2 log
⎛⎝ ∑3h=1 P(m = mh)P(Dj|pˆj,0,M,m = mh,E ,Q)∑3
h=1 P(m = mh)P(D
(1)
j |pˆj,1,M,m = mh,E ,Q)P(D(2)j |pˆj,2,M,m = mh,E ,Q)
⎞⎠ (7)
where Dj is the observed data for both cases and con-
trols, and pˆj,0 is the allele frequency under the null
hypothesis. Other notations are the same as in Equation 6.
Estimating MAF in simulated data
We compare the estimates of allele frequency on simu-
lated data using true genotypes (True), called genotypes
without any filtering (Call NF), called genotypes with
filtering (f = 1; Call F), and the maximum likelihood
method (ML). For rare SNPs, the minor allele type is
often not apparent. When calling genotypes, the second
most common nucleotide is assumed to be the minor
allele. The ML method directly incorporates uncertainty
in determining the minor allele and unless otherwise
stated, results using the unknown minor allele method
(Equation 3) are shown. Note that the unknown minor
allele ML method performs similarly to the known
minor allele ML method but the former better for very
rare SNPs (Additional file 1).
We first evaluated how well the different approaches
were able to estimate the MAF in 200 individuals across
a range of sequencing depths for 1,000 SNPs with a true
MAF of 5%. Figure 1 shows boxplots of the distributions
of estimated MAFs using the four different approaches.
As expected, for higher coverage data, such as an indivi-
dual depth of 12×, all the methods perform as well as
when the genotypes are known with certainty (True).
However, when the depth decreases, the estimates of
the MAF obtained by first calling genotypes become
biased. For example, the median MAF estimated using
the Call F method is 5.3% at 6× coverage and is 12.5%
at 2×. The reason for the upward bias is that it becomes
harder to call heterozygotes since true heterozygotes
often look like sequencing errors. Therefore, more het-
erozygotes than minor homozygotes tend to have miss-
ing genotypes. However, the overall bias in MAF
estimates from called genotypes is not always in one
direction (data not shown). Interestingly, the bias
appears to be worse for the Call F method than the Call
NF method. This pattern may seem counter-intuitive
since filtering the genotype calls would seem to decrease
the probability of calling a sequencing error a heterozy-
gote. However, the Call F method also results in a larger
amount of missing data since many homozygotes for the
major allele will not be called due to sequencing errors.
Thus, in this instance, calling genotypes without filtering
seems to be the better strategy than filtering genotypes
when trying to estimate the MAF.
The results are dramatically different for the new ML
method. This method provides unbiased estimates of
the MAF (median of ~4.9%) across a range of depths.
Even at 2×, the estimates show only a slightly larger var-
iance than those based on the true genotypes.
We also compared the estimated mean squared error
(MSE; Expectation ( (M̂AF − MAF)2 ) of the different
estimates of the MAF across a range of sequencing
depths (Figure 2). The ML method has a lower MSE
than the calling methods with 50 or 200 individuals. In
particular, the MSE computed based on the Call F
method is much higher than those from the other meth-
ods especially when the depth decreases. The MSE of
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the estimates of the MAF based on the true genotypes
reflects the lower limit of the MSE and is not constant
across depths due to sampling variance and a finite sam-
ple size. Using 50 individuals, the MSE approaches
0.0005 with increasing depth and when using a sample
size of 200 individuals, it approaches 0.0013 with
increasing depth.
Overall, the new ML method out-performs genotype
calling methods.
Estimating a distribution of MAFs from simulated data
We next examine how the different estimation
approaches performed in estimating the proportion of
SNPs at different frequencies in the population (similar
to the site frequency spectrum but based on population
allele frequency instead of sample frequency). Here we
simulated 20,000 SNPs where the distribution of the
true MAFs followed the standard stationary distribution
for an effective population size of 10,000 (see Methods).
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Figure 1 Estimates of allele frequency at sites with a true MAF of 5% for different depths of coverage. At each depth, 1,000 sites were
simulated using 200 individuals, and at each site, an estimate of allele frequency is computed using: (1) true genotypes (True); (2) called
genotypes without filtering (Call NF); (3) called genotypes with filtering (Call F); and (4) the maximum likelihood method (ML). For more details
of the estimation methods, see Methods.
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Note that in practice, however, it is very difficult to dis-
tinguish a very rare SNP from a sequencing error.
Therefore, for comparison purpose with real data, we
discarded SNPs with estimated MAF less than 2%.
Figure 3 shows the proportion of SNPs falling into each
different frequency bin after excluding those SNPs with
estimated MAF<2%.
As expected, with a high depth of coverage, such as
10× per individual, all methods provide estimated MAF
distributions that are similar to the expected distribution
based on the true genotypes (Figure 3). With a shal-
lower depth of coverage, such as less than 4× per indivi-
dual, the distributions of MAFs obtained by genotype
calling methods significantly depart from the expected
MAF distribution based on true genotypes (Figure 3). In
particular, these methods over-estimate the proportion
of low-frequency SNPs. For example, the expected pro-
portion of SNPs in the second bin (estimated MAF
between 2-4%) is 18%. The corresponding proportion
based on the Call NF method at a depth of 4× is 26%,
which is 1.4-fold higher than expected. The over-estima-
tion of the proportion of low-frequency SNPs occurs
due to confusion of sequencing errors with true hetero-
zygotes, which results in overcalling heterozygous geno-
types. The magnitude of this inflation differs across
different filtering cutoffs, but a larger cutoff does not
necessarily increase or decrease the inflation.
The picture is entirely different for the ML method.
The estimated MAF distribution obtained from the new
ML method closely follows the true distribution even
with shallow depths of coverage. Here there is almost
no excess of low-frequency SNPs. At a depth of 4×, the
proportion of SNPs in the second bin of the histogram
is 18.4%, which is very close to the expected proportion
(18%). Thus, more reliable estimates of the frequency
spectrum can be made from low-coverage data by using
our likelihood approach than by using the genotype call-
ing approaches.
Association mapping in simulated data
We compare the performance of methods that treat
inferred genotypes as true genotypes in tests of associa-
tion (using a G-test) to our likelihood ratio test (LRT)
that accounts for uncertainty in the genotypes. We
examine the distribution of the test-statistic under the
null hypothesis of no allele frequency difference between
cases and controls. We also compare the power of the
different approaches.
With reasonably large sample sizes, standard asymptotic
theory suggests that under the null hypothesis both the G-
statistic and LRT statistic follow a chi-square distribution
with one degree of freedom (c2(1)). Therefore, we have
compared the null distribution of the G-statistic computed
based on calling methods as well as the LRT statistic to
50 individuals
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Figure 2 Mean squred error (MSE; Expected (M̂AF − MAF)2 ) of four different types of allele frequency estimators for different
sample sizes (left and right panel) and depths of coverage (x-axis). At each depth, MSE was computed from the allele frequency estimates
made using four different methods: True, Call NF, Call F, and ML (for details of the methods, see the caption of Figure 1).
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the c2(1) distribution using QQ-plots (Figure 4). We simu-
lated 5,000 SNPs across a variety of sequencing depths in
500 cases and controls where the MAF used to simulate
genotypes was 5% in both cases and controls. The distri-
bution of the G-statistic computed using the true geno-
types shows a very good correspondence with a c2(1)
distribution. However, the distribution of the G-statistic
computed based on the called genotypes substantially
departs from a c2(1) distribution. Calling genotypes and
then treating those genotypes as being accurate produces
a vast excess of false-positive signals if the p-values are
computed using a c2(1) distribution. For example, at a
depth of 2×, 11% of the SNPs had a p-value less than 5%,
compared to the expected 5%. The effect is caused by an
increase in the variance, due to overcalling homozygotes
as heterozygotes, in the allelic test used here for detecting
association. Genotypic tests such as Armitage trend test,
which are robust to deviations from Hardy-Weinberg
equilibrium, do not show a similar increase in the false
positive rate (Additional file 2). Consistent with this obser-
vation, filtering the called genotypes results in a decrease
in the fraction of significant tests when using the G-test,
although filtering does not completely solve the problem.
On the other hand, the LRT statistic shows only a very
slight departure from a c2(1) distribution for either 2× or
5× depths of coverage.
We also generated receiver operating characteristic
(ROC) curves for each of the different association tests.
These curves show the power of the test at different
false-positive rates. Since the distributions of some of
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Figure 3 Distribution of allele frequencies of SNPs simulated assuming the standard stationary distribution of allele frequencies. At
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the test statistics do not follow the c2(1) distribution
under the null hypothesis, to make a fair comparison,
we obtained the critical value for each false positive rate
based on the empirical null distribution. The power is
computed as the fraction of simulated disease loci that
have a statistic exceeding the critical value. Overall, we
find that the LRTperforms better than the G-test based
on either genotype calling method (Figure 5). For exam-
ple, at a 5% false positive rate and with a sequencing
depth of 5×, the power to detect a disease locus with a
MAF of 1% and a relative risk (RR) of 2 is 51% with the
LRT, but power drops to 33% using the calling method
without filtering and to 34% using the calling method
with filtering. In particular, at low depth, the G-test
applied to called genotypes with filtering performs very
poorly (left most column in Figure 5). If we compare
the power of the LRT to the Armitage trend test using
called genotypes, we find that the LRT also has higher
power than the Armitage trend test (Additional file 3).
This suggests that if one wishes to use called genotypes,
filtering them based on call confidence can result in a
loss of power.
Application to real data
We analyzed 200 exomes from controls for a disease
association study that have been sequenced using Illu-
mina technology at a per-individual depth of 8× [42].
We used the genotype likelihoods generated by the
“SOAPsnp” program [32] for our inference. For more
details, see Methods.
First, we explored the accuracy of the estimates of the
MAF from next-generation sequencing data for 50 SNPs
by comparing them to the estimated MAFs from Seque-
nom genotype data. Both the estimates using the ML
method and the genotype calling method without filter-
ing are highly correlated with the estimates made from
the Sequenom genotype data (i.e., a small standardized
difference between the two estimates in Figure 6). How-
ever, estimates based on genotype calling with filtering
show poor correspondence to the frequencies estimated
from the Sequenom genotype data, especially when
sequencing depth is low. Interestingly, there is one SNP
where the estimated MAF from the resequencing data is
very different from the estimate obtained from the
Sequenom genotype data, even though the sequencing
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Figure 4 QQ-plots comparing the null distribution of the test statistic of interest with a c2(1) distribution. Each column corresponds to a
different test statistic: (1) G-statistic computed using the true genotypes (True); (2) G-statistic computed using called genotypes without filtering
(Call NF); (3) G-statistic computed using called genotypes with filtering (Call F); and (4) the likelihood ratio test statistic with unknown minor
allele (LRT). Assuming 500 cases and 500 controls, under the null hypothesis, a set of 5,000 sites were simulated with a MAF of 5% with a
sequencing depth of 2× (upper panels) and 5× (lower panels). The “Inflation” factor [44] is shown in the upper left corner of each figure.
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depth is very high (14×). Specifically, the estimated MAF
from the Sequenom genotype data is 22.5%, but is 17.2%
when estimated using the ML approach. Individual
examination shows that in many individuals, the highly
supported genotype based on the sequencing data differs
from the Sequenom genotypes. Given that this SNP is
covered by many reads in these individuals and that the
observed read bases have high quality scores (>Q20), it
is likely that the difference is due to Sequenom genotyp-
ing errors. Note that there are a couple of SNPs in
which the estimated MAFs from the genotype calling
approach without filtering seem to better correspond to
the MAFs estimated from the Sequenom genotyping
than the estimates from the ML approach do. For exam-
ple, at one SNP the estimated MAF is 25.7% from the
Sequenom genotype data, 25.9% from the genotype call-
ing method without filtering, and 27.2% from the ML
method. However, individual inspection reveals there
are a few individuals for which the called genotype from
the sequencing data differs from the Sequenom geno-
type. In these cases, the errors in the called genotypes
canceled, giving the appearance of better correspon-
dence with the Sequenom genotype data. Therefore, for
these SNPs, it is hard to tell which method performs
best.
We next examined the distribution of MAFs com-
puted using several approaches across a range of
sequencing depths from our next-generation exome
sequencing data (Figure 7). We discarded SNPs with
estimated MAF <2% since it is difficult to distinguish
these very low-frequency SNPs from sequencing errors
in this dataset. We further removed sites in which there
was a significant difference (p-value less than 10-5 using
a rank-sum-test [43]) in the quality score of read bases
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Figure 5 Receiver operating characteristic (ROC) curves of four tests of association. For the definition of the four statistics, see the caption
of Figure 4. Assuming 500 cases and 500 controls, a set of 20,000 sites were simulated under the null and under the alternative at individual
sequencing depths of 2×, 5×, and 10× (three columns). At each false positive rate (x-axis), the corresponding critical value was computed using
the empirical null distribution. The true positive rate (power; y-axis) was obtained by computing the fraction of causative sites with test statistics
that exceed the critical value.
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between the minor and major alleles. These sites are
likely to be artificial SNPs that may occur due to incor-
rect mapping or unknown biases introduced during the
experimental procedure. Then we classified each site
into bins based on the depth of coverage. The number
of SNPs in each bin is shown in Table 1. When the
average depth is less than 9×, the distributions of esti-
mated MAFs based on genotype calling methods are
very different from the one based on the ML method.
Specifically, the genotype calling approaches give rise to
a large excess of low-frequency SNPs (MAF between 2%
and 4%). This pattern mirrors what was seen in our
simulation studies (Figure 3). Also, for the genotype
calling methods, the allele frequency distribution
changes dramatically as sequencing depth changes.
Therefore, as discussed previously, when depth is not
very high, the genotyping calling methods are likely to
include a lot of false SNPs that are sequencing errors.
These errors appear as an excess of low-frequency SNPs
in the frequency distribution. The distribution based on
the ML method is more stable across depths, but there
still is an excess of SNPs with low allele frequency with
depth less than 9×as compared to the proportion of
low-frequency SNPs at greater depths.
Finally, we used this exome-resequencing data to
simulate a case-control association study. To examine
the distribution of the association test statistics under
the null hypothesis, we randomly assigned 100 indivi-
duals to a case group and the other 100 to the control
group. For all SNPs on chromosome 2 with MAF esti-
mates > 2% (based on the unknown minor allele ML
method), we tested for allele frequency differences
between cases and controls by computing the G-statistic
using called genotypes both with and without filtering
as well as the LRT statistic. Figure 8 shows the QQ
plots comparing the distributions of the test statistics to
the standard c2(1) distribution. As seen in simulation
studies, the null distribution of the G-statistic calculated
when calling genotypes without filtering substantially
departs from the c2(1) distribution. However, the null
distribution of the LRT statistic closely follows the c2(1)
distribution. The inflation factor [44] is 1.01, implying
that LRT statistic performs well when applied to real
data.
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Figure 6 Estimates of allele frequency computed from 200 individuals using next-generation sequencing data vs. Sequenom
genotype data. At each site, only individuals that have both Sequenom genotype data and sequencing data were used for estimation of allele
frequency. For the sequencing data, estimates of MAF were obtained using three different methods (Call NF; Call F; and ML). The standardized
difference for each estimate was computed as
pˆs − pˆg√
pˆs(1 − pˆs)
/
n− pˆg(1 − pˆg)
/
n
, where pˆs and pˆg are the estimated MAFs from the
sequencing data and Sequenom genotype data, respectively, and n is the number of individuals used for the estimation. Each site is classified
into one of four bins based on average individual depth of coverage (color): less than 4×, higher than 4× but less than 8×, higher than 8× but
less than 16×, and higher than 16×.
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Discussion
The likelihood method discussed here is an extension of
our previous approach [30] which was similar to that of
Lynch [29]. We have improved this approach by allow-
ing for uncertainty in determining which allele is the
minor allele. Additionally, the present formulation
includes base-specific error rates (see Equation 8). These
additions may have a practical benefit particularly when
estimating the frequencies of rarer alleles, where it may
not be obvious which allele is the minor allele and
where sequencing errors may have the greatest effect on
frequency estimation.
Though not surprising, it is important to note that
with higher sequencing coverage, the particular
approach used to estimate allele frequencies does not
matter as much. For depths of coverage > 10×, the gen-
otype calling methods both with and without filtering
behave appropriately and similarly to the ML approach.
Thus, with high depths of coverage, the traditional and
simple method of calling genotypes and then treating
those genotypes as being known with certainty is still
effective. The reason for this is that with such high
depth, the called genotypes are likely to be accurate.
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Figure 7 Distribution of the minor allele frequency estimated from the exomes of 200 sequenced individuals. For each site, the minor
allele frequency was estimated using four different methods: (1) the ML method with unknown minor allele, (2) the ML method with a known
or fixed minor allele, (3) calling genotypes without filtering (Call NF), and (4) calling genotypes with filtering (Call F). Each site is classified into
bins based on the depth of coverage. Furthermore, in each histogram, sites with estimated MAF less than 2% are not considered. For the
number of SNPs that were used for this analysis, see Table 1.
Table 1 Number of SNPs with estimated MAF larger than
2% using a particular method (row) within each bin
(column) defined by average sequence depth across
individuals
0.5×-3× 3×-6× 6×-9× 9×-12× 12×-25×
ML (unknown) 18324 12564 9102 6778 11862
ML (known) 15282 11482 8742 6651 11810
Call NF 123546 63415 19516 9695 13035
Call F 391488 21511 10018 7145 12026
Kim et al. BMC Bioinformatics 2011, 12:231
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With lower depths of coverage, however, there is con-
siderable uncertainty regarding the true genotype. Often
the most-likely genotype will not be the true genotype,
leading to biases in estimates of allele frequency and
spurious signals of association in case-control studies. In
this situation, the ML method is a superior approach.
In our simulations, we compared the performance of
our ML approach to a relatively simple genotype calling
approach (see Methods). It is possible that more sophis-
ticated genotype calling approaches such as SOAPsnp
[32], MAQ [23], and GATK [45] may show improved
performance relative to the simple genotype calling
approach used here. However, many of the same trends
found in our simulations, where the simple genotype
calling approach was used, were also seen in the exome
sequencing data where genotypes were called using
SOAPsnp. For example in both the simulations and the
exome data, genotype calling approaches result in the
appearance of an excess of low-frequency SNPs (com-
pare Figure 3 to Figure 7) especially when sequencing
depth is less than 8×per individual.
We have explored whether it is better to call geno-
types with filtering or without filtering when analyzing
low-coverage data. Intuitively, one would expect that if
there was uncertainty in the genotypes, it would be bet-
ter to call genotypes only if one was very confident in
that genotype and treat the other less confident geno-
types as missing data. However, as discussed by Johnson
et al. [46], calling genotypes only when one is very
confident can adversely affect downstream analyses that
use the inferred genotypes. Our simulations and ana-
lyses of real data show that for estimating allele frequen-
cies, genotype calling methods perform better without
any filtering because filtering creates a strong upward
bias in the frequency estimates. For association studies,
it is not always clear whether it is better to filter the
genotypes. Not filtering can result in an excess of false-
positive results for allelic-based tests, but filtering can
result in a decrease in power.
Studies have suggested that genotype calling
approaches that use LD information to call genotypes
[21,36] may result in more accurate inferences from
low-coverage data. However, it is unclear whether using
population genetic characteristics of the data, like LD
patterns, to call genotypes biases downstream popula-
tion genetic and evolutionary analyses. Such an evalua-
tion is beyond the scope of the present work. However,
this is not a concern for our method to estimate allele
frequencies because our approach does not use any LD
information.
As currently implemented our method does not tackle
the problem of SNP calling itself. In principle, our
approach could be extended to use a LRT to call SNPs.
Specifically, the test could compare the probability of
the data under the hypothesis that there is no SNP at a
given site (H0 : p = 0) and under the hypothesis that
there is a SNP at a given site (HA : p > 0). Such an
approach is the subject of ongoing research. A feature
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Figure 8 QQ-plots comparing the association test statistics for allele frequency differences between 100 cases and 100 controls to a
c2(1) distribution. Phenotypes were randomly assigned to indivdiduals in the exome resequencing dataset such that there are 100 cases and
100 controls. For each site, three statistics were computed: the G-statistic using called genotypes without filtering (Call NF), the G-static using
called genotypes with filtering (Call F), and the LRT statistic. To minimize inclusion of false SNPs, sites with ML MAF estimates less than 2% are
discarded. For display purposes, results from sites on chromosome 2 are shown. Note that the inflation factor is shown in the upper left corner
of each QQ-plot.
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of our approach to estimating frequencies is that it
is not necessary to first call SNPs prior to estimating
frequencies, which may be beneficial in certain
circumstances.
Finally, our likelihood method has some limitations. It
cannot estimate the frequencies of very rare alleles from
low-coverage data. This is not so much a deficiency with
the likelihood approach, but instead, speaks to the diffi-
culty in detecting very rare variants using little data in a
background of sequencing errors. To reliably detect and
estimate the frequencies of rare variants with < 1% fre-
quency, higher-coverage sequencing will be required.
However, approaches that take genotype uncertainty into
account may still be important. As shown by Garner [47],
not taking uncertainty into account can lead to an
increased false positive rate in association studies when
sequencing depth varies between cases and controls. Our
approach also assumes that the loci analyzed are in
Hardy-Weinberg equilibrium. While this is a reasonable
assumption for most human populations, our approach
can be extended to consider more complex relationships
between allele frequencies and genotype frequencies. We
want to emphasize that all methods to estimate allele fre-
quency from next-generation sequencing data require that
accurate genotype likelihoods can be calculated. If these
calculations are not accurate, even after recalibration,
none of the methods are likely to perform well.
Conclusions
We have evaluated the performance of a likelihood
method and genotype calling methods to estimate the
minor allele frequency from next-generation sequencing
data. The likelihood method accurately estimates allele
frequencies even when applied to low-coverage data
(e.g., < 4×per individual) since it models the uncertainty
in assigning individual genotypes. However, genotype
calling approaches can lead to biased inferences when
applied to low-coverage data. We have also extended
the likelihood approach to test for differences in esti-
mated minor allele frequency between cases and con-
trols. Through simulations and the analysis of exomes
from 200 individuals, our LRT has appropriate false-
positive rates and higher power than genotype calling
approaches when analyzing low-coverage data. Finally,
we have shown that under certain circumstances, if one
uses genotype calling approaches, it is better to not filter
genotypes based on the call confidence score.
Methods
Simulation studies
We performed extensive simulation studies to compare
the performance of the likelihood methods with meth-
ods based on called genotypes. Specifically, we simulated
data to assess (1) the accuracy of the estimates of the
MAF, (2) the accuracy in estimating the distribution of
MAFs across genome, and (3) statistical power in asso-
ciation mapping studies. Due to computational con-
straints, we simulated SNPs in the sequencing data
directly rather than simulating raw sequencing reads.
We simulated SNPs with a specified MAF, number of
individuals and per-individual sequencing depth. When
simulating causal SNPs in association studies, MAFs for
cases and controls were assigned using a multiplicative
disease model. For this model, the prevalence of the dis-
ease was fixed at 10%. We examined two sets of MAFs
and relative risks. First, the combined MAF in cases and
controls was 1% and the relative risk was 2. Second, the
combined MAF was 5% and the relative risk was 1.5. As
an example, with a combined MAF of 1% and a relative
risk of 2.0, the obtained MAFs for cases and controls are
1.98% and 0.89%, respectively. Each individual genotype
was simulated assuming Hardy-Weinberg equilibrium
with the given MAF. Read bases were then generated for
each individual by copying each allele a Poisson-distribu-
ted number of times with mean equal to the half the speci-
fied individual depth. Each read base then may have been
altered to one of the other three nucleotides at a specified
type-specific sequencing error rate. The type-specific error
rates used to simulate the data were estimated (see below)
from 200 exomes sequenced using the Illumina platform
[42]. The simulation output was summarized as the num-
ber of reads for each of the four nucleotides (A,C,G,T) for
each individual.
We also evaluated the performance of the approaches
to estimate a distribution of MAFs when the specified
allele frequencies were drawn from a the stationary dis-
tribution under a Wright-Fisher model with a popula-
tion size of 10,000. Under such a model, population
allele frequencies are proportional to 1/x, where x is the
frequency of the allele in the population [48]. Given the
population allele frequency for each site, genotypes and
read counts were simulated as described above.
Various methods have been proposed to compute gen-
otype likelihoods from next-generation sequencing data,
which recalibrate quality scores of read bases and attempt
to correct for sequencing error structures and other com-
plexities in the genome [23,32]. However, for practical
reasons, our simulation studies use a simple genotype
likelihood mainly based on the number of reads for each
base and globally-determined base-specific sequencing
error rates. This model is described below.
The data consist of the observed counts of each of the
four nucleotides (nAi,j, nCi,j, nGi,j, nTi,j) in each indivi-
dual i at site j. Denote the twelve base-specific sequen-
cing error rates as Eb,b′ , where εb,b’ = P(read = b’|allele =
b), where b, b’ Î {A, C, G, T} and b ≠ b. Given these error
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rates, the likelihood for genotype g(Î {0, 1, 2}) is com-
puted as follows:
P(Di,j|g,Eb,b′) = P(nAi,j,nCi,j,nGi,j,nTi,j|g,Eb,b′)
= P(nmi,j,nMi,j,no1i,j,no2i,j|g,Eh,h′)
= Multinomial((nmi,j,nMi,j,no1i,j,no2i,j) | (p(g,E)m , p(g,E)M , p(g,E)o1 , p(g,E)o2 ))
(8)
p(g,E)m =
( g
2
)
(1 − εmM − εmo1 − εmo2) +
(
1 − g
2
)
εMm
p(g,E)M =
(
1 − g
2
)
(1 − εMm − εMo1 − εMo2) +
( g
2
)
εmM
p(g,E)o1 =
( g
2
)
εmo1 +
(
1 − g
2
)
εMo1
p(g,E)o2 =
( g
2
)
εmo2 +
(
1 − g
2
)
εMo2,
where m,M, o1 and o2 denote for the minor allele, major
allele, and other two nucleotides, respectively (the order of
other two nucleotides does not matter). Note that the
counts of four nucleotides are re-ordered as counts of
minor, major, and other two nucleotides (nmi,j, nMi,j, no1i,j,
no2i,j), and the set of error rates is also re-arranged to Eh,h′ ,
where h, h’ Î {m, M, o1, o2} for each site. These genotype
likelihoods were computed from our simulated datasets.
The globally-determined base-specific sequencing error
rates were set to the true values used to simulate the data
(estimated from 200 exome sequencing data [42]; see Addi-
tional file 4), since in practice 10,000 sites were enough to
obtain stable estimates of the type-specific error rates.
Analysis of of real data
We also analyzed 200 Danish exomes that had been
sequenced using Illumina technology at a coverage of
about 8×per individual [42]. These individuals were con-
trols selected for a disease mapping study. We used the
genotype likelihoods generated by the “SOAPsnp” pro-
gram [32] for our inference.
We examined the performance of the ML approach as
applied to this dataset in three different ways. First, we
used 50 SNPs in which Sequenom genotype data were
available in most of individuals to compare the MAFs esti-
mated from the Illumina sequencing data to those esti-
mated from the genotype data. Here, for each site, we
used only those individuals that have both genotype data
and sequence data. For most of the sites (>95%), more
than 170 individuals satisfy this condition. Second, we
examined the proportion of SNPs with different frequen-
cies when using different strategies to estimate the MAFs.
Finally, we used these data to simulate a case-control asso-
ciation study by randomly assigning 100 exomes to a case
group. We then examined the behavior of the different
test statistics under the null hypothesis.
Availability of software
All the source code used for our simulation studies, esti-
mation of parameters, and tests of association are pub-
licly available (Additional files 5 and 6).
Additional material
Additional file 1: Boxplot of estimated MAFs using ML methods
with known or unknown minor allele. Boxplot of estimated MAFs of
SNPs corresponding to each sample allele frequency. Assuming 1,000
individuals, 1,000 SNPs with true MAF of 0.5% were simulated at
individual sequencing depth of 8X. For each SNP, sample allele frequency
was obtained using true genotypes (x-axis). Then each boxplot was
drawn using estimated MAFs with known (left) and unknown(right)
minor alleles.
Additional file 2: QQ-plot comparing the null distribution of the
Armitage trend test statistic with a c2(1) distribution. QQ-plots
comparing the null distribution of the test statistic of interest with a c2
(1) distribution. The first three columns correspond to the Armitage trend
test statistic computed using the true genotypes (True), called genotypes
without filtering (Call NF), and called genotypes with filtering (Call F),
respectively. The fourth column corresponds to the likelihood ratio test
statistic with unknown minor allele (LRT). Assuming 500 cases and 500
controls, under the null hypothesis, a set of 5,000 sites were simulated
with a MAF of 5% with a sequencing depth of 2× (upper panels) and 5×
(lower panels). The “Inflation” factor [44] is shown in the upper left
corner of each figure.
Additional file 3: Receiver operating characteristic curve of the
Armitage trend test. Receiver operating characteristic (ROC) curves of
four tests of association. For the definition of the four statistics, see the
caption of Additional file 2. Assuming 500 cases and 500 controls, a set
of 20,000 sites were simulated under the null and under the alternative
at individual sequencing depths of 2×, 5×, and 10× (three columns). At
each false positive rate (x-axis), the corresponding critical value was
computed using the empirical null distribution. The true positive rate
(power; y-axis) was obtained by computing the fraction of causative sites
with test statistics that exceed the critical value.
Additional file 4: Estimates of type-specific sequencing error rates.
Type-specific sequencing error rates estimated from 200 exomes [42]
using our models (Equation 8).
Additional file 5: Manual of our programs: simreseq and testassoc.
Manual of our programs: simreseq and testassoc.
Additional file 6: Source code of our programs: simreseq and
testassoc. All the source code of our programs used for the simulation
studies, estimation of parameters, and tests of association.
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